Cadrenal Therapeutics, Inc. Common Stock

General ticker "CVKD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $15.7M (TTM average)

Cadrenal Therapeutics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -21.9%.

Estimated limits based on current volatility of 12.3%: low 6.76$, high 8.65$

Factors to consider:

  • Total employees count: 3 as of 2022
  • Current price 11.0% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [7.99$, 27.11$]
  • 2025-12-31 to 2026-12-31 estimated range: [4.38$, 16.19$]

Financial Metrics affecting the CVKD estimates:

  • Negative: with PPE of -1.7 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -40.53 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Net income
  • Positive: Shareholder equity ratio, % of 73.49 > 63.39
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term CVKD quotes

Long-term CVKD plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $2.70MM $7.63MM $10.96MM
Operating Income $-2.70MM $-7.63MM $-10.96MM
Non-Operating Income $-4.01MM $-0.72MM $0.31MM
Interest Expense $0.11MM $0.02MM $0.00MM
R&D Expense $0.39MM $4.08MM $4.21MM
Income(Loss) $-6.71MM $-8.36MM $-10.65MM
Profit(Loss)* $-6.71MM $-8.36MM $-10.65MM
Stockholders Equity $-5.55MM $7.69MM $7.44MM
Assets $0.78MM $8.52MM $10.12MM
Operating Cash Flow $-1.20MM $-3.53MM $-7.36MM
Capital expenditure $0.00MM $0.00MM $0.01MM
Investing Cash Flow $-0.00MM $-0.00MM $-0.01MM
Financing Cash Flow $1.24MM $11.90MM $8.98MM
Earnings Per Share** $-8.66 $-9.63 $-8.73

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.